Dupont Capital Management’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-4,041
Closed -$149K 1661
2022
Q1
$149K Sell
4,041
-358
-8% -$14K 0.01% 1168
2021
Q4
$200K Buy
+4,399
New +$230K 0.01% 1106
2019
Q4
Sell
-16,721
Closed -$378K 1245
2019
Q3
$378K Sell
16,721
-1,793
-10% -$49.7K 0.01% 894
2019
Q2
$666K Buy
+18,514
New +$593K 0.02% 665

Other funds holding CDNA

Dupont Capital Management's CDNA Position: Q2 2022 in Review

Dupont Capital Management sold out of CareDx (CDNA) in Q2 2022, closing a stake of 4,041 shares — an estimated $149K sold.

Dupont Capital Management first reported a position in CDNA in Q2 2019 and held it in 4 quarters. The position peaked at $666K in Q2 2019. 184 funds tracked by Wall St. Rank hold CDNA as of Q2 2022.

  • Dupont Capital Management reported no remaining CareDx position as of Q2 2022 after selling out during the quarter.
  • Dupont Capital Management sold 4,041 CareDx shares in Q2 2022, an estimated $149K.
  • Dupont Capital Management first reported a position in CareDx in Q2 2019 and held it in 4 quarters.
  • Dupont Capital Management's CareDx position peaked at $666K in Q2 2019.
  • 184 funds tracked by Wall St. Rank held CareDx as of Q2 2022.

Based on Dupont Capital Management's 13F filing for Q2 2022, filed 26 Jul 2022.